InvestorsHub Logo

midastouch017

01/26/21 11:34 AM

#17 RE: Amatuer17 #6

RYTM is not cheap as it has market cap of $832 million for pre-revenue biotech - so it is richly valued.



Are you kidding? You know what the mc is today?

Market Cap 1.737B

Since you introduced me to this company it has doubled
in price, if it was richly valued then, what is it now?

But this is besides my previous point - namely i 'missed'
the entry point.